United Kingdom-Runcorn: Contract for the Supply of Stockpiled Medicines

Type of document: Invitation to tender
Country: United Kingdom
OJEU Ref: (2020/S 095-228326/EN)
Nature of contract: Supply contract
Procedure: Open procedure
Type of bid required: Global bid

Contract notice
Supplies

Section I: Contracting authority
I.1) Name and addresses
Official name: Secretary of State for Health and Social Care acting as part of the Crown through the Department of Health and Social Care
Postal address: 2nd Floor, Rutland House
Town: Runcorn
Postal code: WA7 2ES
Country: United Kingdom
Email: Lynne.Nichols@dhsc.gov.uk
Internet address(es):
Main address:

The contract is awarded by central purchasing body
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge,at:
Additional information can be obtained from:
the above mentioned address
Tenders or requests to participate must be submitted:
electronically via:
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local sub-divisions
I.5) Main activity
Health

Section II: Object
II.1) Scope of the procurement
II.1.1) Title: Contract for the Supply of Stockpiled Medicines

Reference number: CM/EMP/20/1622
II.1.2) Main CPV code: 33600000
II.1.3) Type of contract: Supplies
II.1.4) Short Description: Procurement exercise for a contract for the supply of stockpiled medicines to include: lopinavir/ritonavir — tablets or oral solution; hydroxychloroquine — tablets; dexamethasone — oral solution or tablets and azithromycin — capsules, tablets or oral solution. Deliveries will be required over an initial period between 15th June and 30 September 2020 with an option to extend for up to an additional 4 months.
The Authority’s preferred presentations and strengths of the medicines and alternative presentations and strengths and presentations which may be acceptable, are specified in the procurement documents.
II.1.5) Estimated total value:
Value excluding VAT: 35000000.00 Currency: GBPII.1.6) Information about lots:
The contract is divided into lots: Yes
Tenders may be submitted for all lots
II.2) Description
II.2.1) Title: Lopinavir/Ritonavir — Tablets or oral Solution

Lot No:1
II.2.2) Additional CPV code(s)
33600000

II.2.3) Place of performance
Nuts code: UK
Main site or place of performance:To a location in England to be notified to the successful bidder(s) following contract award.
II.2.4) Description of the procurement:
This procurement exercise may result in one or more contracts for the provision of lopinavir/ritonavir tablets or oral solution.
The volumes required by the Authority are up to 1.4 million tablets in packs of up to 120 tablets
II.2.5) Award criteria

II.2.7) Duration of the contract,framework agreement or dynamic purchasing system
Start: 2020-06-15End: 2021-01-31
This contract is subject to renewal: no
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options yes
Description of options: The contract has the option to be extended for up to an additional 4 months and the option for the authority to order an additional volume of the goods to be procured by up to 50 % subject to the agreement of the supplier.

II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:no
II.2.14) Additional information: Lots may be awarded to more than one supplier depending on the volume offered and in accordance with the Authority’s requirements as further specified in the procurement documents.

II.2.1) Title: Hydroxychloroquine — tablets

Lot No:2
II.2.2) Additional CPV code(s)
33600000

II.2.3) Place of performance
Nuts code: UK
Main site or place of performance:To a location in England to be notified to the successful bidder(s) following contract award.
II.2.4) Description of the procurement:
This procurement exercise may result in one or more contracts for the provision of hydroxychloroquine tablets.
The volumes required by the authority are up to 16 million tablets in packs of up to 100 tablets.
II.2.5) Award criteria

II.2.7) Duration of the contract,framework agreement or dynamic purchasing system
Start: 2020-06-15End: 2021-01-31
This contract is subject to renewal: no
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options yes
Description of options: The contract has the option to be extended for up to an additional 4 months and the option for the Authority to order an additional volume of the goods to be procured by up to 50 % subject to the agreement of the supplier.

II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:no
II.2.14) Additional information: Lots may be awarded to more than one supplier depending on volume offered and in accordance with the Authority’s requirements as further specified in the procurement documents.

II.2.1) Title: Dexamethasone — Oral Solution or Tablets

Lot No:3
II.2.2) Additional CPV code(s)
33600000

II.2.3) Place of performance
Nuts code: UK
Main site or place of performance:To a location in England to be notified to the successful bidder(s) following contract.
II.2.4) Description of the procurement:
This procurement exercise may result in one or more contracts for the provision of dexamethasone 2 mg/5 ml oral solution.
The volumes required by the authority are up to 7 000 litres in either 75 ml or 150 ml bottles.
II.2.5) Award criteria

II.2.7) Duration of the contract,framework agreement or dynamic purchasing system
Start: 2020-06-15End: 2021-01-31
This contract is subject to renewal: no
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options yes
Description of options: The contract has the option to be extended for up to an additional 4 months and the option for the authority to order an additional volume of the goods to be procured by up to 50 % subject to the agreement of the supplier.

II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:no
II.2.14) Additional information: Lots may be awarded to more than one supplier depending on the volume offered and in accordance with the authority’s requirements as further specified in the procurement documents.

II.2.1) Title: Azithromycin — Capsules, Tablets or oral Solution

Lot No:4
II.2.2) Additional CPV code(s)
33600000

II.2.3) Place of performance
Nuts code: UK
Main site or place of performance:To a location in England to be notified to the successful bidder(s) following contract.
II.2.4) Description of the procurement:
This procurement exercise may result in one or more contracts for the provision of Azithromycin 250 mg capsules.
The approximate volumes required by the authority are up to 20 million capsules in packs of up to 6 capsules.
II.2.5) Award criteria

II.2.7) Duration of the contract,framework agreement or dynamic purchasing system
Start: 2020-06-15End: 2021-01-31
This contract is subject to renewal: no
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted: no
II.2.11) Information about options
Options yes
Description of options: The contract has the option to be extended for up to an additional 4 months and the option for the authority to order an additional volume of the goods to be procured by up to 50 % subject to the agreement of the supplier.

II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:no
II.2.14) Additional information: Lots may be awarded to more than one supplier depending on volume offered and in accordance with the authority’s requirements as further specified in the procurement documents.

Section III: Legal, economic, financial and technical information
III.1) Conditions for participation
III.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents

Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure:
Open procedure
Accelerated procedure
Justification:The Covid-19 outbreak has given rise to an urgent need for the supply of lopinavir/ritonavir — tablets or oral solution; hydroxychloroquine – tablets; dexamethasone — oral solution or tablets and azithromycin — capsules, tablets or oral solution because the authority needs to be in a position to treat the population as required. This does not give the Authority sufficient time to comply with the standard open procedure timescales for this procurement. The authority considers this to be a state of urgency which it has duly substantiated. Accordingly, the authority is using the accelerated time limits permitted under the Public Contract Regulations 2015 (Regulation 27(5) for the open procedure) in respect of this procurement.
IV.1.8) Information about the Government Procurement Agreement(GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2) Administrative information
IV.2.2) Time limit for receipt of tenders or requests to participate
Date: 2020-05-29 Local time: 13:00
IV.2.4) Languages in which tenders or requests to participate may be submitted:EN
IV.2.6) Minimum time frame during which the tender must maintain the tender
Tender must be valid until:2020-07-31
IV.2.7) Conditions for opening tenders
Date: 2020-05-29 Local time: 13:00
Information about authorised persons and opening procedure:Department of Health and Social Care employee.

Section VI: Complementary information
VI.1) Information about recurrence:
This is a recurrent procurement: no
VI.2) Information about electronic workflows
VI.3) Additional information:
Any supplier may be disqualified who does not respond to the following in the requisite manner:
1) Submission of expression of interest and procurement specific information
This procurement exercise will be conducted on the eTendering portal at Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested), through the eTendering portal as follows:
1.1) If not already registered, Candidates should register on the eTendering portal at and click the link to register:
— accept the terms and conditions and click continue;
— enter your correct business and user details;
— note the username you chose and click ‘Save’ when complete,
— you will shortly receive an email with your unique password (please keep this secure).
1.2) Once registered, candidates must express interest as follows:
(a) login to the eTendering portal;
(b) select ‘Response to ITT’;
(c) select ‘ITTs Open To All Suppliers’;
(d) access listing related to this procurement contract for the supply of stockpiled medicines and view details;
(e) click on “Express interest” button at the top of the page.
(f) Once you have expressed interest, the ITT will move to ‘My ITTs’, where you can download additional documentation (if required), and construct your reply as instructed. You must then publish your reply using the ‘Publish’ button.
1.3) For any support in registering on the portal or submitting your expression of interest please contact the eTendering Help-desk at +44 800 069 8630 or help@bravosolution.co.uk
2) General supplier information.
To manage and assess supplier information the contracting authority requests candidates provide their company profile in the Governments supplier information database, Supplier Registration, as follows:
2.1) If not already registered, candidates must go to the following web page and select ‘Register’ at the top right of the page. Key in details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link at the right of the page to obtain a number from D&B. Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S® Number to enable registration on supplier registration.
2.2) Once registration is complete you are able to create and update your registered company profile. Candidates should ensure all the mandatory fields of their sid4gov profile are completed and up to date for each procurement exercise. D&B data will be supplied automatically by D&B.
2.3) For further help or information concerning supplier registration, please contact the Helpdesk at: support@nqc.com or telephone +44 (0) 845 299 2994.
The contract(s) is for the benefit of the contracting authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.
VI.4) Procedures for review
VI.4.1) Review body
Official name: The High Court
Town: London
Postal code: WCA 2LL
Country: United Kingdom
VI.5) Date of dispatch of this notice:2020-05-13